Speaking during a visit to the production line of the vaccine, he said that Fakhra vaccine has successfully undergone the first and second phases of clinical trial.
The vaccine’s Phase three of clinical trial has already begun so that the vaccines is now allowed to be used in emergency and general vaccination, the minister said.
Ashtiani said that the Defense Ministry is currently capable of producing some one million doses of Fakhra vaccine, noting that Iran is capable enough to increase production by several times of the current capacity within the next three months.
9341**1424
Follow us on Twitter @IrnaEnglish